Morilyte™ is
scientifically validated
Many clinical studies confirm that the proprietary diosmectite is highly effective for the relief and management of acute and chronic diarrhoea. Some of the studies are shown below.

1. Diosmectite significantly decreased stool output in children with acute watery diarrhoea by 33%

    Two parallel double-blind studies of children aged one to 36 months old

Section Reference:
Dupont C et al Oral diosmectite reduces stool output and diarrhoea in children with acute watery diarrhoea. Clinical Gastroenterology and Hepatology 2009;17:456-462

Previous | Next

Copyright © 2013 by InQpharm Group. All rights reserved. Last updated: July 2013 | ID: MM/TM/EN/13/002
Morilyte and InQpharm are trademarks of the InQpharm group of companies.